73 related articles for article (PubMed ID: 38604154)
1. RAC1
Shi X; Chen W; Yin Y; Cao H; Wang X; Jiang W; Li Q; Li X; Yu Y; Wang X
Cancer Lett; 2024 Jun; 592():216909. PubMed ID: 38679407
[TBL] [Abstract][Full Text] [Related]
2. Single-cell profiling reveals the metastasis-associated immune signature of hepatocellular carcinoma.
Zhong D; Shi Y; Ma W; Liang Y; Liu H; Qin Y; Zhang L; Yang Q; Huang X; Lu Y; Shang J
Immun Inflamm Dis; 2024 May; 12(5):e1264. PubMed ID: 38780041
[TBL] [Abstract][Full Text] [Related]
3. Prognostic effect of CTLA4/LAG3 Expression by T-Cells Subsets on Acute Myeloid Leukemia Patients.
El Dosoky W; Aref S; El Menshawy N; Ramez A; Abou Zaid T; Aref M; Atia D
Asian Pac J Cancer Prev; 2024 May; 25(5):1777-1785. PubMed ID: 38809650
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and genomic characteristics of intrahepatic metastases of primary liver cancer.
Zou W; Fang Z; Feng Y; Gong S; Li Z; Li M; Sun Y; Ruan X; Fang X; Qu H; Li H
BMC Cancer; 2024 Jun; 24(1):672. PubMed ID: 38824541
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma from an immunologic perspective.
Greten TF; Duffy AG; Korangy F
Clin Cancer Res; 2013 Dec; 19(24):6678-85. PubMed ID: 24030702
[TBL] [Abstract][Full Text] [Related]
6. Tissue damage from chronic liver injury inhibits peripheral NK cell abundance and proinflammatory function.
You Z; Ling S; Zhao S; Han H; Bian Y; He Y; Chen X
J Leukoc Biol; 2024 May; 115(6):1042-1052. PubMed ID: 38315633
[TBL] [Abstract][Full Text] [Related]
7. Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma.
Zheng X; Jin W; Wang S; Ding H
Front Immunol; 2021; 12():729705. PubMed ID: 34566989
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
9. Single-cell data revealed exhaustion of characteristic NK cell subpopulations and T cell subpopulations in hepatocellular carcinoma.
Cui Z; Li H; Liu C; Wang J; Chen C; Hu S; Zhao X; Li G
Aging (Albany NY); 2024 Apr; 16(7):6550-6565. PubMed ID: 38604154
[TBL] [Abstract][Full Text] [Related]
10. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles.
Wu M; Mei F; Liu W; Jiang J
Biomed Pharmacother; 2020 Jan; 121():109637. PubMed ID: 31810126
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of Tumor-Infiltrating CD49a
Sun H; Liu L; Huang Q; Liu H; Huang M; Wang J; Wen H; Lin R; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
Cancer Immunol Res; 2019 Sep; 7(9):1535-1546. PubMed ID: 31311791
[TBL] [Abstract][Full Text] [Related]
13. PD1
Ma J; Zheng B; Goswami S; Meng L; Zhang D; Cao C; Li T; Zhu F; Ma L; Zhang Z; Zhang S; Duan M; Chen Q; Gao Q; Zhang X
J Immunother Cancer; 2019 Nov; 7(1):331. PubMed ID: 31783783
[TBL] [Abstract][Full Text] [Related]
14. The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma.
Agdashian D; ElGindi M; Xie C; Sandhu M; Pratt D; Kleiner DE; Figg WD; Rytlewski JA; Sanders C; Yusko EC; Wood B; Venzon D; Brar G; Duffy AG; Greten TF; Korangy F
Cancer Immunol Immunother; 2019 Apr; 68(4):599-608. PubMed ID: 30688989
[TBL] [Abstract][Full Text] [Related]
15. Amphiregulin couples IL1RL1
Sun R; Zhao H; Gao DS; Ni A; Li H; Chen L; Lu X; Chen K; Lu B
Sci Adv; 2023 Aug; 9(34):eadd7399. PubMed ID: 37611111
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]